|
Customer reported falsely elevated patient blood lead test results with leadcare ii.Customer reported blood lead test kit (lot 2602m, sublot unknown) level 1 and level 2 controls were within range upon opening according to package insert instructions.Customer reported level 1 control values of 10.7 ug/dl, 11.7 ug/dl and 10.8 ug/dl (target range of 8.8 to 14.8 ug/dl) on (b)(6) 2026, respectively.Customer reported level 2 control values of 29.6 ug/dl, 29.5 ug/dl and 28.8 ug/dl (target range of 27.1 to 35.9 ug/dl) on (b)(6) 2026, respectively.Customer reported an elevated leadcare ii pediatric patient blood lead test result of 3.7 ug/dl with corresponding confirmatory test result of less than 1.0 ug/dl.Customer reported hnl performed confirmation testing.Customer was unable to provide a copy of confirmation test results as results go directly into electronic patient charts.During troubleshooting technical services (ts) asked the customer to describe their method applied for collecting and preparing capillary blood.The customer described procedures that align with the instructions for use (ifu).Customer confirmed they do not use secondary micro-collection devices to collect patient samples.Customer reported bringing a single capillary tube and plunger along with the treatment reagent (tr) tube into the patient collection room.Ts recommended bringing the whole container of capillary tubes and plungers to avoid contamination.Customer reported using gloves without powder.Customer reported there was no construction taking place in the area of the facility.Customer reported their leadcare ii analyzer's sensor deck was clean and the prongs were golden.Customer reported they cleaned the sensor deck with an alcohol wipe.Ts recommended cleaning the sensor deck with a dry cloth.Customer reported using the ac adapter to power the leadcare ii analyzer.On (b)(6) 2026 the regional point of care (rpoc) visited the customer's facility.Rpoc reported the customer stocked the entire container of capillary tubes and plungers in the patient collection rooms.Magellan provided 5 additional sets of capillary tube and plunger containers to the customer to store in each patient collection room.On (b)(6) 2026 customer confirmed receipt of capillary tubes and plungers.Customer reported they would continue to monitor testing.On (b)(6) 2026 the customer reported testing was going well and they plan to monitor for an additional week.Ts to follow up.Magellan diagnostics received the customer's leadcare ii analyzer for further investigation on (b)(6) 2026.Ts attempted to follow up with the customer on (b)(6) 2026.No additional communication has been received by the customer to date.
|